Paper: Final Results from the Phase 2 Revive Study Investigating the Hepcidin Mimetic Rusfertide in Patients with Polycythemia Vera (PV)
Program: Oral and Poster Abstracts Session: 634. Myeloproliferative Syndromes: Clinical and Epidemiological: Poster III Hematology Disease Topics & Pathways: Research, Clinical trials, MPN, Drug development, Clinical Research, Chronic Myeloid Malignancies, Diseases, Treatment Considerations, Myeloid Malignancies Aaron T. Gerds, MD, MS 1, Andrew T. Kuykendall, MD 2, Marina Kremyanskaya, MD, PhD 3, Ellen K. Ritchie, MD 4, Jason Gotlib, MD, MS 5, Jeanne Palmer, MD 6, Kristen M. Pettit, MD 7, Victor Priego,
